Insider trades

Richard A. Zordani Jr., Director of Galectin Therapeutics GALT, has filed 5 purchases and 0 sales on the open market. The latest trade was on 01/16.

Richard A. Zordani Jr.

Director
First filing
23/01/30
Trades
9 trades
Buys / sales
5 / 0
12-month net buying
No record
Last trade
01/16

Trading activity

Transactions

Trade type
Open-market buy24/12/2424/12/2610,000 sh$0.82$8,200+31.2%
GALT
Open-market buy24/08/22–24/08/2324/08/263,500 sh3 trades$2.30avg.$8,050No record
Open-market buy24/04/3024/04/301,000 sh$3.52$3,520No record